Cardiac Electrophysiologist. Outcomes investigator. Implanter. Extractor. Ablationist. Regulatory enthusiast.
Joined July 2011
- Tweets156
- Following120
- Followers404
- Likes178
Emily Zeitler retweeted
#OriginalResearch: Left atrial appendage occlusion was associated with a lower risk of death, stroke and bleeding compared to anticoagulation among females and males @EmilyZeitler @JonHsuMD @AndreaRussoEP @drdevignair @djdardenMD @MCoylewright ahajrnls.org/41eMXif
Emily Zeitler retweeted
Contemporary Trends in Cardiac Electrophysiology Procedures in the United States, and Impact of a Global Pandemic, by @monte_scott, @ba_steinberg, and colleagues
heartrhythmopen.com/article/…
At least I'm consistent. Whenever I don't know what to do, I remap. Am I right, #EPeeps ?
So much work to do but inspired by this work with @KateKiernanMD @LarryRJacksonII @ECGMD @shayne_dodge
Racial and ethnic differences in implantable cardioverter-defibrillator patient selection, management, and outcomes, by @EmilyZeitler and colleagues
#HRO2GlobalVoices
heartrhythmopen.com/article/…
The best leadership and networking opportunity for #womeninEP Meet your professional soulmates @docAnneSquared @ciorsti @aartisdalal @cm_beach
Would you like to influence other #WomeninEP and push EP as a career choice to reduce gender disparities? Apply to HRS' Growth & Leadership Opportunity for Women in EP (#GLOWE) w/ Chair @AndreaRussoEP & VC @netta_doc. Applications are due by Feb. 3, 2023. heartrhythmsociety.smapply.i…
Deeply feeling the absence of @laurenggilstrap now more than ever. Thank you @JCardFail for this remembrance. We all have so much to live up to. @DrMarkCreager
Thank you #LynneStevenson & #MarkCreager for helping us pay homage to #LaurenGilstrap and her legacy @JCardFail 🙏🏽
May we honor her memory - she was one of us.
@robmentz
onlinejcf.com/article/S1071-…
So much to learn about the neuro-cardiac connections in arrhythmia care! @TJaredBunch @AndreaRussoEP @ba_steinberg @JonPicciniSr Thanks to @BiosenseWebster for support !
Open Access: Comparative risk of dementia among patients with atrial fibrillation treated with catheter ablation versus anti-arrhythmic drugs. pubmed.ncbi.nlm.nih.gov/3624…
#Cardiology #Afib @EmilyZeitler @AndreaRussoEP
Emily Zeitler retweeted
Open Access: Comparative risk of dementia among patients with atrial fibrillation treated with catheter ablation versus anti-arrhythmic drugs. pubmed.ncbi.nlm.nih.gov/3624…
#Cardiology #Afib @EmilyZeitler @AndreaRussoEP
Can't wait to meet you! You all look awfully smart... Must be #EPeeps in the making.
We are so excited to welcome our next class of #cv #fellows to @DHCVFellowship @DHHeartVascular . We can’t wait to meet everyone! @DrMarkCreager @CynthiaTaub @DadekianGreg @mnyoung1 @CapnIntrvention @DeVriesJt @stanhenkin
Wish I could take credit for this wisdom but it was passed on to me by the great @SanaAlkhatib9 !
@EmilyZeitler giving great advice at a @WomenAs1 conference this am: “Be a finisher. If you finish what you say yes to - you will be way ahead of the pack.” Incredibly insightful advice for #earlycareer #cardiotwitter
There are no words. No words that could do this brilliant, humane, adventurous, indefatigable human justice. We were so lucky to love her. My heart is broken.
rickerfuneralhome.com/obitua…
Emily Zeitler retweeted
Now online @Heart_BMJ, our analysis of ~60,000 patients undergoing catheter ablation for #AFib showing ↑ risk of longer hospitalization stays, major/specific adverse events, and lower quality of life in women 🫀 @jfreeMD @EmilyZeitler @YaleCardiology
heart.bmj.com/content/early/…
Credit goes to @US_FDA @FDADeviceInfo for striving towards a regulatory paradigm that is unobtrusive to clinical care while allowing post market data collection to inform device design and regulatory decisions.
Hot off the press!!! #JICE
A "Design/Rationale" paper describing the EP PASSION project for monitoring and developing real world data for CIEDs, CIED monitoring, and/or device-related complications.⬇️
rdcu.be/cJSGR
#Epeeps #CardioTwitter #MedTwitter
Emily Zeitler retweeted
We have launched ‘Advocacy in Action’ w/ @HRSonline President-Elect Jodie Hurwitz, MD, FHRS. In the first episode @jhurwitz55 sits w/ HRS Health Policy Chair, Christopher Liu, MD, FHRS to discuss 2023 @CMSGov proposed #reimbursement cuts. Full 🎥 here > bit.ly/3OwwXjJ
These changes are having a tremendous and possibly underappreciated impact on the device development ecosystem. Work from the #3DSymposium.
Pleased to see our manuscript in JSCAI on how the new EU Regulations (MDD to MDR) are upending med device evaluation and commercialization @dhh, @EmilyZeitler, @MyJSCAI
doi.org/10.1016/j.jscai.2022…
And now I'm wondering if this was intentional to appeal to my impulse to help those in true editorial need... Well played, predatory journal, well played.
Couldn't agree more, @AndreaRussoEP ! What a fabulous program. This is @HRSonline delivering true mentorship and advocacy. Can't wait for the #GLOWE 2023 reunion.
Congratulations to the graduating GLOWE class and welcome to the class of 2023! Thanks to the leadership of @jenniferavari and Riki Green, hard work of Moriah Vincent, and support of @pavblake and @HRSonline leadership Fred Kusumoto, @AndrewKrahnMD @jhurwitz55 @EP_mom1
It's that time of year to #GoRedNH. Today and every day. Also, we have the BEST #WIC @DHHeartVascular . @laurenggilstrap @CynthiaTaub
Just in time to inform important and pressing coverage policy discussions related to emerging technologies. @laurenggilstrap @SanaAlkhatib9 @JonSkinner17 @MCoylewright
Coverage With Evidence Development: Where Are We Now? ajmc.com/view/coverage-with-… via @AJMC_Journal
Emily Zeitler retweeted
Are you an early career EP? Want to learn new skills, expand your network & increase your visibility with industry partners? @WomenAs1 wants to help #EPeeps Apply to the 2022 CLIMB Cardiac EP program now! This is your #TIMETOCLIMB. @HRSonline bit.ly/3NddoOj